Vitrolife AB (publ) (STO:VITR)
Sweden · Delayed Price · Currency is SEK 117.80
+2.60 (2.26%)
Nov 4, 2026, 5:29 PM CET
Vitrolife AB Market Cap
Vitrolife AB has a market cap or net worth of 15.64 billion as of November 4, 2026. It is the 7,612th most valuable company in the world and the 101st biggest in Sweden. Its market cap has decreased by 19.71% in one year.
Market Cap
15.64B
Enterprise Value
16.50B
Revenue
3.44B
Global Rank
Country Rank
#101 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 27, 2001, Vitrolife AB's market cap has increased from 510.85M to 15.64B, an increase of 2,960.64%. That is a compound annual growth rate of 14.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 15.64B | -15.73% |
| Dec 30, 2025 | 18.55B | -36.27% |
| Dec 30, 2024 | 29.11B | 10.43% |
| Dec 29, 2023 | 26.36B | 4.56% |
| Dec 30, 2022 | 25.21B | -66.75% |
| Dec 30, 2021 | 75.82B | 223.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 75.99B |
| Sectra AB | 62.96B |
| Elekta AB | 23.88B |
| Nolato AB | 13.87B |
| MedCap AB | 8.40B |
| Xvivo Perfusion AB | 6.33B |
| CellaVision AB | 4.77B |
| BICO Group AB | 1.70B |